anti-CD19 CAR T cell therapy / University of Erlangen- Nuremberg Medical School - LARVOL DELTA

World-First CAR T-Cell Therapy for Child With Lupus (Technology Networks) - "The girl, who is now 16 years old, was the first child with SLE to receive the immune therapy as part of an individual treatment attempt at Deutsches Zentrum Immuntherapie (DZI) at Universitätsklinikum Erlangen....'We initiated the CAR-T cell therapy for Uresa as part of an extended access program for severely ill patients in accordance with the German Medicinal Products Act and the Ordinance on Medicinal Products for Compassionate Use'...Uresa was given a mild course of chemotherapy to prepare for the treatment that made some space for the CAR-T cells in her blood at the BMT ward of the Department of Pediatrics and Adolescent Medicine...All her symptoms gradually disappeared...In conjunction with the pediatric oncology department, pediatric rheumatologist Krickau is now planning a study with other children and teenagers with automimmune diseases..."

Clinical • Systemic Lupus Erythematosus